Advertisement

PharmacoEconomics & Outcomes News

, Volume 841, Issue 1, pp 17–17 | Cite as

DTaP booster not cost effective unless pertussis incidence high

Clinical study
  • 4 Downloads

Reference

  1. Havers FP, et al. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States. Vaccine : 31 Oct 2019. Available from: URL: https://doi.org/10.1016/j.vaccine.2019.09.104

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations